Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pathological mechanism of secondary-progressive multiples sclerosis and its animal model.
Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.
HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.
Alterations of the human gut microbiome in multiple sclerosis.
Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
Age at onset and seizure frequency affect white matter diffusion coefficient in patients with mesial temporal lobe epilepsy.
Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis.
Intravenous Immunoglobulins Lower Inflammatory Gene Expression in Skin Biopsies of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
Effect of oscillating electrical field stimulation on motor function recovery and myelin regeneration after spinal cord injury in rats.
Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer.
Recurrent myelopathy and optic neuritis associated with systemic lupus erythematosus.
Ubiquitination of RORγt at Lysine 446 Limits Th17 Differentiation by Controlling Coactivator Recruitment.
Variations in multiple sclerosis practice within Europe - Is it time for a new treatment guideline?
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Comparison of Quantitative Cerebral Blood Flow Measurements Performed by Bookend Dynamic Susceptibility Contrast and Arterial Spin-Labeling MRI in Relapsing-Remitting Multiple Sclerosis.
Olfactory dysfunction as a marker of multiple sclerosis progression.
Two - Dimensional Potentials of Mean Force of Nile Red in Intact and Damaged Model Bilayers. Application to Calculations of Fluorescence Spectra.
Altered Mitochondrial Dynamics Contributes to Propofol-induced Cell Death in Human Stem Cell-derived Neurons.
Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).
Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
A case of a 17-year-old male with neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy presenting with tremor and ataxia.
Progressive Multifocal Leucoencephalopathy and psoriasis.
Comparison of histopathological effects of perineural administration of bupivacaine and bupivacaine-dexmedetomidine in rat sciatic nerve.
Pages
« first
‹ previous
…
810
811
812
813
814
815
816
817
818
…
next ›
last »